The macrophage and neuropsychiatric disorders

Neuropsychiatry, Neuropsychology and Behavioral Neurology

Volumn 9, Issue 1, 1996, Pages 16-29

  Fricchione, Gregory L ^a   Bilfinger, Thomas V ^b   Stefano, George B ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Aids; Alzheimer's disease; Cytokines; Delirium; Depression; Macrophges; Microglia; Neuro; Schizophrenia

Indexed keywords

CYTOKINE; NEUROPEPTIDE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DELIRIUM; DEMENTIA; DEPRESSION; HUMAN; IMMUNE SYSTEM; MACROPHAGE; MENTAL DISEASE; MICROGLIA; NEUROPSYCHIATRY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0030026376     PISSN: 0894878X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Stefano GB. Role of opioid neuropeptides in immunoregulation, Progr Neurobiol 1989;33:149-59.
2. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989;69:1-32.
3. Stefano GB. Bilfinger TV, Fricchione GL. The immune-neurolink and the macrophages: postcardiotomy delirium, HIV-associated dementia and psychiatry. Progr Neurobiol 1994: 42:475-88.
4. Goetzl E, Streedharan SP, Harkonen WS. Pathogenic roles of neuroimmunologic mediators. Immunol Allergy Clin North AM 1989;8:183-9.
5. Zajicek JP, Wing M, Scolding NJ, Compston DAS. Interactions between oligodendrocytes and microglia. Brain 1992; 1611-31.
6. Merrill JE. Macroglia: neural cells responsive to lymphokines and growth factors. Immunol Today 1987;8:146-50.
7. Perry VH, Hume DA. Gordon S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 1985;15:313-26.
8. Thomas WE. Brain macrophages: evaluation of microglia and their functions. Brain Res Review 1992;17:61-74.
9. Perry VH, Gordon S. Macrophages and the nervous system. Intl Rev Cytology 1991;125:203-44.
10. Guilian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986;6:2163-78.
11. Guilian D, Chen J, Ingeman JE, George J, Noponen M. Study of inflammatory response to traumatic brain injury in the adult mammal. I. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989;9:4416-29.
12. Perry VH. The role of macrophages in models of neurological and psychiatric disorder. Psychol Meet 1992;22:551-5.
13. Stefano GB, Smith EM, Cadet P, Hughes TK. HIV GP120 alteration of DAMA and IL-1α induced chemotoxic responses in human and invertebrate immunocytes. J Neurommunol 1993;43:177-84.
14. Kushner I. The phenomenon of the acute phase reaction. Ann NY Acad Sci 1982;389:39-48.
15. Mohankumar PS, Thyagarajan S, Quadri SK. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci 1991;48(9): 925-30.
16. Palazzolo DL, Quadri SK. Interleukin-1 stimulates catecholamine release from the hypothalamus. Life Sci 1990;47: 2105-9.
17. Brown R, Price RJ, King MG, Husband AJ. Interleukin-1 beta and muramyl dipeptide can prevent decreased antibody response associated with sleep deprivation. Brain Behav Immunity 1989;3:320-39.
18. Weidenfeld J, Abramsky O. Ovadia H. Evidence for the involvement of the central adrenergic system in interleukin-1 induced adrenocortical response. Neuropharmacology 1989; 28:1411-4.
19. Shintani F, Kanba S, Kakaki T, et al. Interleukin-1 beta augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J Neurosci 1993;13:3574-3581.
20. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993;329:1246-53.
21. Sawada M. Hara N, Maeno T. Ionic mechanism of the outward current induced by extracellular ejection of interleukin-1 onto identified neurons of aplasia. Brain Res 1991;545:248-56.
22. Szucs A, Stefano GB, Hughes TK, S-Rozsa K. Modulation of voltage-activated ion currents on identified neurons of helix pomatia L by interleukin-1. Cell Mol Neurobiol 1992;12:429-38.
23. Schöbitz B, DeKloet ER, Holsboer F. Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain. Progr Neurobiol 1994;44:397-432.
24. Scarborough DE. Somatostatin regulation by cytokines. Metabolism 1990;39:108-11.
25. Goldblum SE, Cohen DA, Jay M. McClain CJ. Interleukin-1 induced depression of iron and zinc: role of granulocytes and lactoferrin. Am J Physiol 1987;252.E27-32.
26. Waltrip JW, Carrigan DR, Carpenter WT. Immunopathology and viral reactivation. A general theory of schizophrenia. J Nery Ment Dis 1990;178:729-38.
27. Ben-Shachar D. Finberg JPM. Youdim MBH. Effect of iron chelators on dopamine D2 receptors. J Neurochem 1985;45: 999-1005.
28. Rosebush PI, Mazurek MF. Serum iron and neuroleptic malignant syndrome. Lancet 1991;338:149-51.
29. Frederickson CJ, Danscher G. Zinc-containing neurons in hippocampus and related CMS structures. Progr Brain Res 1990;83:71-84.
30. Stengaard-Pederson K, Fredens K, Larsson L. Enkephalin and zinc in the hippocampal mossy fiber system. Brain Res 1981;212:230-3.
31. Ebadi M, Hama Y. Zinc-binding proteins in the brain. In: Schwarcz R, Ben-Ari Y, ed. Excitatory Ammo Acids and Epilepsy. New York: Plenum Press. 1986:557-70.
32. Barbanel G, Ixart G, Szafarczyk A, Malavel F, Assenmacher I. Intrahypothalamic infusion of interleukin-1 best increases the release of corticotropin-releasing (CRH 41) and adrenocorticotropic hormone (ACTH) in free moving rats bearing a push-pull cannula in the median eminence. Brain Res 1990;516:31-6.
33. Hurwitz AA, Berman JW, Lyman WD. The role of the blood-brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol 1994;4:249-56.
34. Perry VH, Gordon E. Modulation of CD4 on macrophages and microglia in rat brain. J Exp Med 1987;166:1138-43.
35. Bredt D, Snyder S. Nitric oxide: a novel neuronal messenger. Neuron 1992;8:8-12.
36. Moncada S, Higgs A. The L-Arginine Nitric Oxide pathway. N Engl J Med 1993;329:2002-12.
37. Lowenstein CJ, Dinerman JL. Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
38. Schuman EM. Madison DV. A requirement for the intercellular messenger nitnc oxide in long-term potentiation. Science 1991;254:1503-6.
39. Schuman EM, Madison DV. Locally distributed synaptic potentiation in the hippocampus. Science 1994;263:532-6.
40. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-22.
41. Zielasek J, Tausch M, Toyka KV, Hartung HP. Production of nitrate by neonatal rat microglial cells/brain macrophages. Cell Immunol 1992;141:111-20.
42. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent myobacteriam avium and to kill arvirulent M. arrum: killing effector mechanism depends on the generation of reactive mitogen intermediates. J Leuk Biol 1991;49:380-7.
43. Ashwell K. Development of microglia in the albino rabbit retina. J Comp Neurol 1989;287:286-301.
44. Aruffo C. Ferozi R, Hildebrandt AG, Cervos-Navarro J. Low doses of L-monosodium glutamate promotes neuronal growth and differentiation in vitro. Dev Neurosci 1987;9:228-39.
45. Olney JW. Excitatory amino acids and neuropsychiatrie disorders. Biol Psychiatry 1989;26:505-25.
46. Brown MC, Perry VH, Lunn ER, et al. Macrophage dependence of peripheral sensory nerve regeneration: possible involvement of nerve growth factor. Neuron 1991;6:359-70.
47. Frei K, Malipiero UV, Leist TP, Zinkenagel RM, Schwab ME, Fontana A. On the cellular source and function of IL-6 produced in the central nervous system in viral diseases. Eur J Immunol 1989;19:689-94.
48. Benes FM, Turtle M, Kahn Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence and adulthood. Arch Gen Psychiatry 1994;54:477-84.
49. Benes FM. Cingulate cortex in schizophrenia and other psychiatric disorders. In: Vogt BA, Gabriel M, eds. The neurobiology of cingulate cortex and limbic thalamus. Boston, MA: Birkhauser, 1993:581-605.
50. Eiden L. Foreword to Neuro-AIDS. Adv Neuroimmunol 1994;4:145-8.
51. Brenneman DE, McCune SK, Mervis RF, Hill JM. GP120 as an etiologic agent for Neuro-AIDS: neurotoxicity and animal models. Adv Neuroimmunol 1993;4:157-65.
52. Dawson TM. Dawson VL. GP120 neurotoxicity in primary cortical cultures. Adv Neuroimmunol 1994;4:167-73.
53. Ljpton SA. Yeh M, Dreyer EB. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv Neuroimmunol 1994;4: 181-8.
54. Lipton SA. Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995: 332:934-40.
55. Tyor WR, Glass JD, Gnffin JW, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31:349-60.
56. Lipton SA. Neurobiology: HIV displays its coat of arms. Nature 1994;367:113-4.
57. Wesselingh SL, Glass J, McArthur JC, Griffin JW, Griffin DE. Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol 1994;4:199-206.
58. Heyes M. (Reviewed by Black R. Sager R.) Summary of workshop contributions. Adv Neuroimmunol 1994;4:149-56.
59. Gelman BB. Diffuse microgliosis associated with cerebral atrophy in acquired immunodeficiency syndrome. Ann Neurol 1993;34:65-70.
60. McGeer PL. McGeer EG, Akiyama H, Itagaki S, Harrop R, Peppard R. Neuronal degeneration and memory loss in Alzheimer's disease and aging. Exp Brain Res 1990;21:411-26.
61. McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer's type are positive for the histocompatibihty glycoprotein HLA-DR. Neurosci Lett 1987;79:195-200.
62. Filit H, Ding W, Buce L, et al. Elevated circulating tumor necrosis factor levels in Alzheimer's Disease. Neurosci Lett 1991;129:318-20.
63. Itagaki S, McGeer PL, Akiyama H. Presence of T-cytotoxic suppressor and leukocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci Let 1988;91:259-64.
64. Potter H, Nelson RB, Das S, et al. The involvement of proteases. protease inhibitors, and an acute phase response in Alzheimer's disease. Ann NY Acad Sci 1992;674:161-73.
65. Bornstein DL. Leukocytic pyrogen: a major mediator of the acute phase reaction. Ann NY Acad Sci 1982;389:323-37.
66. Struttmatter WJ, Saunders AM, Schemechel D, et al. Apolipoprotein E high affinity binding to β-amyloid and increased frequency of type 4 allele in familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-81.
67. Peacock ML, Fink JK. Apo E epsilon 4 allelic association with Alzheimer's disease independent confirmation using denaturing gradient electrophoresis. Neurology 1994;44:339-41.
68. Mahley R. Apolipoprotein E cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-9.
69. Snipes GJ, McGuire CB, Nordeen JJ, Freeman JA. Nerve injury stimulates the secretion of apolipoprotein E by mononeural cells. Proc Natl Acad Sci USA 1986;83:1130-4.
70. Ignatius MJ, Gebicke-Haerter PJ, Skine JHP, et al. Expression of apolysoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 1986;83:1125-9.
71. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Leu 1992;135:235-6.
72. Breitner JCS, Gall BA. Welsh KA, et al. Inverse associations of anti-inflammatory treatments and Alzheimer's disease. Neurology 1994;44:227-32.
73. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 1994:151:1105-13.
74. Pert C, Smith C, Ruff C, Hill J. AIDS and its dementia as a neuropeptide disorder: role of VIP receptor blockade by human immunodeficiency virus envelope. Ann Neurol 1988: 23(suppl):S71-3.
75. Saper CB, Breder CD. The neurologic basis of fever. N Engl J Med 1994;330:1880-6.
76. Dunn AJ. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther 1992;261(3):964-9.
77. Chrousos GP, Gold PW, The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-52.
78. Harris DNF, Bailey SM, Smith PLC, Taylor KM, Oatridge A, Bydder GM. Brain swelling in first hour after coronary artery bypass surgery. Lancet 1993;342:586-7.
79. Schackert G, Simmons RD, Buzbee TM, Hume DA, Fidler IJ. Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier. J Natl Cancer Inst 1988;80:1027-34.
80. Nathan CF. Secretory products of macrophage. J Clin Invest 1987;79:319-26.
81. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-9.
82. Hamburger V, Oppenheim RW. Naturally occurring cell death in vertebrates. Neurosci Comment 1982;1:39-55.
83. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17:319-34.
84. Hüttenlocker PR. Synaptic density in human frontal cortex: developmental changes and effects of aging. Brain Res 1979; 163:195-205.
85. Guilian D, Allen RL, Baker TJ, Tomozaura Y. Brain peptides and glial growth. I. Glia promoting factors as regulators of gliogenesis in the developing and injured centra! nervous system. J Biol 1986;102:803-20.
86. Guilian D, Woodward J, Young DG, et al. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988;8:2485-90.
87. Guilian D, Baker TJ. Peptides released by amoeloid microglia regulate astroglial proliferation. J Cell Biol 1985;101:2411-5.
88. Akbarian S, Bunney WE, Potkin SG, et al. Altered distribution of nicotinamide-adenme dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993;50:169-77.
89. Akbarian S, Viñuela A, Kim JJ. Potkin SG, Bunney WE, Jones EG. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 1993;50:178-87.
90. Hendry SHC, Jones EG, Emson PC. Morphology distribution and synaptic relations of somatosiatin and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex. J Neurosci 1984;4:2497-517.
91. Hoffman RE, Dobscha SK. Cortical pruning and the development of schizophrenia: a computer model. Schizophrenia Bull 1989;15:477-89.
92. Stevens J, Casanova M. Is there a neuropathology of schizophrenia? Biol Psychiatry 1988;24:123-8.
93. Goodman R. Neuronal misconnections and psychiatric disorder. Is there a link? Br J Psychiatry 1989;154:292-9.
94. Roberts GW. Schizophrenia: a neuropathological perspective. Br J Psychiatry 1991;158:8-17.
95. Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 1991;48:413-7.
96. Angrist BM, Gershon S. The phenomenology of experimentally induced amphetamine psychosis - preliminary observations. Biol Psychiatry 1970;2:95-107.
97. Oilman A, Goodman LS. Pharmacological basis of therapeutics. New York: Macmillan, 1985.
98. Licinio J, Seibyl JP, Altemus M, Charney DS, Xrystal JH. Elevated CSF levels of Interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry 1993;150:1408-10.
99. Guilian D, Tapscott MJ. Immunoregulation of cells within the central nervous system. Brain Behav Immunol 1988;2: 352-8.
100. Lapchak PA, Araiyo DM, Quirion R, Beaudet A. Immunoediographic localization of interleukin-2-iike immunoreactivity and interleukin-2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience 1991;44:173-84.
101. O'Callaghan E, Sham P, Takai N, Glover G, Munay RM. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 1991;337:1248-50.
102. Mednick SA. Machon RA, Huttenen MO, Bonet D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189-92.
103. LaFosse JM, Mednick SA. Comment regarding schizophrenia and influenza. Lancet 1991;338:118.
104. O'Callaghan E, et al. Reply to comment. Lancet 1991;338: 119.
105. Jacob H, Beckmann H. Gross and histological criteria for developmental disorders in brains of schizophrenics. J R Soc Med 1989;82:466-9.
106. Ringler GE, Coutifaris C, Strauss JF, Allen JI, Geier M. Accumulation of colony stimulating factor 1 in amniotic fluid during human pregnancy. Am J Obstet Gynecol 1989;160: 655-6.
107. Kendall RE, Kemp IW. Maternal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 1989;46:878-82.
108. Bowler AE, Torrey EF. Influenza and schizophrenia. Arch Gen Psychiatry 1990;47:877.
109. Pert CB, Knight JG, Laing P, Markwell MK. Scenarios for a viral etiology of schizophrenia. Schizophrenia Bull 1988;14: 243-7.
110. Torrey EF. Hypotheses on the seasonal it y of schizophrenic births. In: Cazullo CL, Invernizzi G, Sacchetti E, Vita A, eds. Etiopathogenic hypotheses of schizophrenia London, MTP Press, 1988.
111. Torrey EF. Stalking the schizovirus. Schizophrenia Bull 1988;14:223-9.
112. Bloom FE. Advancing a neurodevelopmental origin for distribution. Arch Gen Psychiatry 1993;50:224-7.
113. Mednick SA, Cannon TO. Fetal development birth and the syndromes of adult schizophrenia. In: Mednick SA. Cannon TO, Barr CE, Lyon M, eds. Fetal neural development and adult schizophrenia. New York: Cambridge University Press, 1991.
114. Richman DP. Stewart RM, Hutchinson JW, Caviness VS. Mechanical model of brain convolutional development. Science 1975;189:18-21.
115. Kostovic I, Rakic P. Developmental history of the transient subplate zone in the visual and somato-sensory cortex of the macaque monkey and human brain. J Comp Neurol 1990;297:441-70.
116. Smith RS. The macrophage theory of depression. Med Hypoth 1991;35:298-306.
117. Maes M, Bosmano E, Meltzer H, Scharpe S, Suy E. Interleukin-1β: a putative mediator of HPA axis hyperactivity in major depression. Am J Psychiatry 1993;150:1189-93.
118. Plata-Salaman CR. Immunomodulators and feeding regulation: a humoral link between the immune and nervous systems. Brain Behav Immunity 1989;3:193-213.
119. Smith RS. The immune system is a key factor in the etiology of psychosocial disease. Med Hypoth 1991;34:49-57.
120. Macs M, Smith R, Scharpe S. The monocyte T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995;20:111-6.
121. Fricchione GL, Mendoza AY. Stefano GB. Morphine and its psychiatric implications. Adv Neuroimmunol 1994;42:475-88.
122. Stefano GB, Scharrer B. Endogenous morphine and related opiates: a new class of chemical messengers. Adv Neuroimmunol 1994;4:57-68.